Back to SCLN Stock Lookup

SCLN – Analyst Ratings

Mar 12, 2014 03:05 PM Aegis Capital Still Firm on SciClone Pharma (SCLN) Following Q4 Results; Zadaxin Opportunity Still Robust
Jan 28, 2014 11:20 AM No Impact Expected from Change in Auditor at SciClone Pharma (SCLN); China Looks Better - Analyst (GSK)
Nov 12, 2013 02:49 PM Aegis Capital Cuts PT on SciClone (SCLN) to $8; China Restrictions Will Hamper N-T Results
Sep 25, 2013 11:33 AM Addition of Nancy Chang to Board Will Benefit SciClone (SCLN), Maintain Buy - Aegis
Jul 16, 2013 08:40 AM Aegis Capital Upgrades SciClone Pharmaceuticals (SCLN) to Buy
Sep 18, 2012 10:11 AM BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy, Risk Removed
Aug 13, 2012 07:26 AM Cowen Downgrades SciClone Pharmaceuticals (SCLN) to Neutral
Jul 25, 2012 10:13 AM Aegis Capital Starts SciClone Pharmaceuticals (SCLN) at Buy
Dec 12, 2011 09:51 AM Cowen Starts SciClone Pharmaceuticals (SCLN) at Outperform
Aug 10, 2010 08:55 AM BWS Financial Downgrades SciClone Pharmaceuticals (SCLN) to Hold; SEC Investigation Overhang
May 17, 2010 09:46 AM BWS Financial Maintains Bullish Bias on SciClone Pharmaceuticals (SCLN)
Apr 9, 2010 08:17 AM BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy
Nov 11, 2009 08:12 AM National Securities Initiates Coverage on SciClone Pharmaceuticals (SCLN) with a Buy
Jul 8, 2009 08:34 AM BWS Financial Downgrades SciClone Pharmaceuticals (SCLN) to Hold; Valuation Call After Recent Run-Up
Jun 3, 2009 07:54 AM ThinkEquity Initiates Coverage on SciClone (SCLN) with a Buy
Nov 7, 2008 10:11 AM Susquehanna Maintains a Positive Rating on SciClone Pharmaceuticals (SCLN)
Sep 5, 2008 09:19 AM Susquehanna Initiates Coverage on SciClone Pharmaceuticals (SCLN) with a Neutral
Aug 9, 2005 08:06 AM Jefferies Downgraded SCLN

Back to SCLN Stock Lookup